Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

IRIDEX Corporation

IRIX
Current price
2.75 USD -0.04 USD (-1.43%)
Last closed 2.77 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 44 681 448 USD
Yield for 12 month +23.32 %
Week
Month
Year
IRIX
21.11.2021 - 28.11.2021

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California. Address: 1212 Terra Bella Avenue, Mountain View, CA, United States, 94043

Analytics

WallStreet Target Price

3 USD

P/E ratio

Dividend Yield

1.12 %

Current Year

+56 972 000 USD

Last Year

+53 903 000 USD

Current Quarter

+12 850 000 USD

Last Quarter

+12 855 000 USD

Current Year

+25 368 000 USD

Last Year

+22 831 000 USD

Current Quarter

+5 621 000 USD

Last Quarter

+5 363 000 USD

Key Figures IRIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -7 771 000 USD
Operating Margin TTM -13.14 %
PE Ratio
Return On Assets TTM -13.04 %
PEG Ratio -0.44
Return On Equity TTM -51.48 %
Wall Street Target Price 3 USD
Revenue TTM 54 606 000 USD
Book Value 0.74 USD
Revenue Per Share TTM 3.4 USD
Dividend Share
Quarterly Revenue Growth YOY -12.2 %
Dividend Yield 1.12 %
Gross Profit TTM 25 368 000 USD
Earnings Share -0.48 USD
Diluted Eps TTM -0.48 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -14.21 %

Dividend Analytics IRIX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IRIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 1.12 %
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation IRIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.7311
Price Sales TTM 0.8183
Enterprise Value EBITDA -5.8734
Price Book MRQ 3.7306

Financials IRIX

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators IRIX

For 52 weeks

1.31 USD 3.48 USD
50 Day MA 2.55 USD
Shares Short Prior Month 177 366
200 Day MA 2.18 USD
Short Ratio 1.66
Shares Short 319 217
Short Percent 2.23 %